1. Home
  2. IDYA vs GPOR Comparison

IDYA vs GPOR Comparison

Compare IDYA & GPOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$39.98

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Gulfport Energy Corporation

GPOR

Gulfport Energy Corporation

HOLD

Current Price

$182.04

Market Cap

3.1B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
GPOR
Founded
2015
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.1B
IPO Year
2019
1998

Fundamental Metrics

Financial Performance
Metric
IDYA
GPOR
Price
$39.98
$182.04
Analyst Decision
Strong Buy
Buy
Analyst Count
16
11
Target Price
$52.86
$233.33
AVG Volume (30 Days)
701.7K
297.2K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
245.92
EPS
N/A
13.82
Revenue
$218,710,000.00
$1,422,583,000.00
Revenue This Year
N/A
$18.35
Revenue Next Year
$201.05
$6.04
P/E Ratio
N/A
$12.98
Revenue Growth
3024.43
48.47
52 Week Low
$23.23
$149.18
52 Week High
$42.68
$225.78

Technical Indicators

Market Signals
Indicator
IDYA
GPOR
Relative Strength Index (RSI) 58.13 71.20
Support Level $33.57 $173.75
Resistance Level $39.93 $188.82
Average True Range (ATR) 1.35 3.91
MACD 0.09 0.80
Stochastic Oscillator 59.26 96.30

Price Performance

Historical Comparison
IDYA
GPOR

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About GPOR Gulfport Energy Corporation

Gulfport Energy Corp is an independent natural gas-weighted exploration and production company focused on the exploration, acquisition, and production of natural gas, crude oil, and natural gas liquids, with assets located in the Appalachia and Anadarko basins in the United States. The principal properties of the company are located in eastern Ohio, targeting the Utica and Marcellus, and in central Oklahoma, targeting the SCOOP Woodford and Springer formations.

Share on Social Networks: